Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells
GLP-1s were associated with lower risk of complications for those already having a substance use disorder Among people who already had a substance use disorder, starting a GLP-1 medication was associated with fewer substance-related emergency department visits, hospital admissions, overdose events, episodes of suicidal ideation or attempts, and lower mortality (see graph below)
SGLT2 brain expression is lower compared to SGLT1, and it is localized mainly in the microvessels of the blood-brain barrier, in the amygdala, hypothalamus, periaqueductal gray, and in the dorsomedial medulla (Enerson and Drewes, 2006)
Is PT-141 safe
Pregnant and nursing women should consult a physician before taking any supplements